Thyroid

Papers
(The H4-Index of Thyroid is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
International Women’s Day: An Occasion for a Tribute to Women Leaders in the American Thyroid Association202
Geraldo A. de Medeiros-Neto, MD, MACP (June 5, 1935–January 21, 2022)167
Future Meetings166
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal146
Future Meetings103
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer87
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Thyroid83
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma76
Role of Thyrotropin-Releasing Hormone in Regulating Fibroblast Growth Factor 21 in Mouse Pancreatic β Cells76
35th Anniversary of Thyroid—Journal of the American Thyroid Association74
Regular Call Oral Abstracts74
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants68
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study59
Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations58
Maternal Exercise Before and During Pregnancy Facilitates Embryonic Myogenesis by Enhancing Thyroid Hormone Signaling55
The Scientific Contributions of Martin Surks, MD, MACP: A Pioneer in Thyroid Hormone Physiology, Subclinical Hypothyroidism, and Endocrine Education53
Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions52
A Conversation with Samuel Refetoff, MD: How Treating One Family Stimulated a Lifelong Series of Major Discoveries in Thyroid Physiology and Disease48
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction47
Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis46
Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.45
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)43
Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up43
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy40
A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications38
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease38
Incidence and Temporal Patterns of Differentiated Thyroid Carcinoma in Children and Adolescents in Germany: A Pooled Analysis Based on Data from the German Malignant Endocrine Tumor Registry and the G36
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005–202036
Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers35
Abstract Author Index35
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward35
Correction to: The Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/T35
Delayed Thyrotropin Rise in Preterm Newborns: Value of Multiple Screening Samples and of a Detailed Clinical Characterization34
Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis34
The Year in Thyroidology: Surgical Science34
Retrospective Analyses of 18FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center34
0.065781116485596